WeDaita

Research Digest

AI-curated papers, approvals, clinical compounds, and disclosures from drug discovery's leading sources.

Scored for relevance by WeDaita AI · Updated weekly · Not editorial content

Genetic, genomic, and functional evidence for novel drug targets — from GWAS associations to CRISPR screens and industry pipeline updates.

  • Literature — Peer-reviewed studies on target biology, CRISPR screen hits, GWAS associations, and druggability assessments (PubMed, arXiv, Semantic Scholar)
  • Industry News — Company announcements, partnership deals, and pipeline updates on early-stage target programs
Literature
VioLA: Learning Generalist Humanoid Control Policies from Human Data
Oct 8, 2026 · wedaita-biomed-mcp · Mert Albaba; Jens Beißwenger; Anna Manasyan; Daniel Marta; …
Literature
FAITH: Feasibility-Aware Safety-Filtered RL for High-Dimensional Systems
Oct 8, 2026 · wedaita-biomed-mcp · Songyuan Zhang; Baljeet Singh; Sarthak Ranjeet Kaingade; Ch…
Industry News
Live-cell transcriptomics
Oct 8, 2026 · Nature Genetics · Petra Gross